[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352321-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352321-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ier3-promotes-malignant-progression-of-colorectal-cancer-through-the-nf-b-pathway","IER3 Promotes Malignant Progression of Colorectal Cancer Through the NF-κB Pathway","","Colorectal cancer remains a major cause of cancer mortality, driven by metastatic progression and an immunosuppressive tumor immune microenvironment (TIME). The stress-responsive gene IER3 is dysregulated across cancers, yet its role in colorectal cancer pathogenesis and immune modulation is unclear. Integrated single-cell RNA sequencing identifies an IER3-expressing malignant subpopulation linked to aggressive disease. Functional and mechanistic studies show IER3 promotes proliferation, invasion, and metastasis via TNF-α/NF-κB signaling and enhances an immunosuppressive TIME through the FN1–CD44 axis, supporting immune escape and therapy resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ier3-promotes-malignant-progression-of-colorectal-cancer-through-the-nf-b-pathway/352321/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ier3-promotes-malignant-progression-of-colorectal-cancer-through-the-nf-b-pathway/352321.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does IER3 play in colorectal cancer progression?","Question",{"text":63,"@type":64},"IER3 promotes CRC proliferation, invasion, and metastatic capacity, defining an aggressive IER3-expressing malignant subpopulation linked to poor prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does IER3 mechanistically activate immune-escape programs?",{"text":68,"@type":64},"IER3 activates the TNF-α/NF-κB pathway, increasing RELA/p65 activity, and reshapes the tumor immune microenvironment toward immunosuppression, partly via the FN1–CD44 axis.",{"name":70,"@type":61,"acceptedAnswer":71},"How does IER3 expression relate to immune checkpoint blockade response?",{"text":72,"@type":64},"Higher IER3 expression correlates with reduced response to immune checkpoint blockade and distinct drug sensitivity profiles.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352321,1790112474,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Wiley  \nInternational Journal of Genomics Volume 2026, Article ID 8379666, 34 pages [https://doi.org/10.1155/ijog/8379666](https://doi.org/10.1155/ijog/8379666)  \nResearch Article  \nIER3 Promotes Malignant Progression of Colorectal Cancer Through the NF-κB Pathway  \nZhigang Wei, 1,2 Yinyi Luo ,3 Yupeng Zhang,3 Qingxing Huang,4 Jianhang Shao,3 Yingying Zhang , 1 Yuqi Zhang,3 Zhimin Wang,4 Chaojie Liang,2 Zhiyong Lai ,2 and Yongping Cui 1,5  \n1Department of Pathology, School of Basic Medical Science, Shanxi Medical University, Taiyuan, China  \n2Department of Biliary and Pancreatic Surgery, The First Hospital, Shanxi Medical University, Taiyuan, China  \n3 The First Clinical Medical School, Shanxi Medical University, Taiyuan, China  \n4Department of Colorectal Surgery, The First Hospital, Shanxi Medical University, Taiyuan, China  \n5Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China  \nCorrespondence should be addressed to Zhiyong Lai; 609774722@qq.com and Yongping Cui; [cuiypsx@163.com](cuiypsx@163.com)  \nReceived 9 October 2025; Revised 14 November 2025; Accepted 16 December 2025  \nGuest Editor: Pengpeng Zhang  \nCopyright © 2026 Zhigang Wei et al. International Journal of Genomics published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nColorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, primarily due to metastatic progression and an immunosuppressive tumor immune microenvironment (TIME) . The stress-responsive gene IER3 is found to bedysregulated in multiple cancers. Currently, its functional role in CRC pathogenesis and immune modulation remains poorly understood. Here, using integrated single-cell RNA sequencing (scRNA-seq) of clinical samples, we identify a distinct IER3-expressing malignant subpopulation associated with aggressive disease and poor prognosis. Functional studies demonstrate that IER3 drives CRC proliferation, invasion, and metastatic capacity both in vitro and in vivo. Mechanistically, IER3 activates the TNF-α/NF-κB signaling pathway, thereby enhancing the expression and phosphorylation of RELA/p65 . Moreover, IER3+ malignant cells reshape the TIME into an immunosuppressive state by altering immune cell inﬁltration and promoting communication via the FN1–CD44 axis. High IER3 expression correlates with reduced response to immune checkpoint blockade (ICB) and distinct drug sensitivity proﬁles. Together, these ﬁndings conﬁrm that IER3 is a dual critical mediator of CRC progression and immune escape, highlighting its potential as a therapeutic target and biomarker for personalized treatment strategies.  \nKeywords: colorectal cancer; immune checkpoint blockade; immune escape; immunosuppression; tumor immune  \nmicroenvironment  \n1. Introduction  \nColorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second leading cause of cancerrelated mortality worldwide [1, 2] . Its poor prognosis is largely attributed to the high frequency of hepatic metastasis [3, 4] . Thus, elucidating the biological mechanisms driving CRC progression, identifying predictive biomarkers, and discovering novel therapeutic targets remain major challenges in current research.  \nAccumulating evidence indicates that the tumor immune microenvironment (TIME) of CRC is markedly immunosuppressive, characterized by an expansion of immunosuppressive cell populations accompanied by reduced inﬁltration and impaired cytotoxicity of CD8+ T cells and NK cells, collectively leading to compromised immune surveillance [5–7] . Although these studies have outlined the immunosuppressive features of CRC, the speciﬁc malignant subclones responsible for TIME remodeling and the mechanisms involved remain poorly understood  \n2 International Journal of Genomics  \nThe stress-respons","cbCailbw1rXOZ52D","https://ap.wps.com/l/cbCailbw1rXOZ52D","pdf",9520635,34,"English","# Introduction\n## Tumor immune microenvironment in colorectal cancer\n## IER3 dysregulation and its controversial roles\n## Study design using single-cell RNA sequencing","[{\"question\":\"What role does IER3 play in colorectal cancer progression?\",\"answer\":\"IER3 promotes CRC proliferation, invasion, and metastatic capacity, defining an aggressive IER3-expressing malignant subpopulation linked to poor prognosis.\"},{\"question\":\"How does IER3 mechanistically activate immune-escape programs?\",\"answer\":\"IER3 activates the TNF-α/NF-κB pathway, increasing RELA/p65 activity, and reshapes the tumor immune microenvironment toward immunosuppression, partly via the FN1–CD44 axis.\"},{\"question\":\"How does IER3 expression relate to immune checkpoint blockade response?\",\"answer\":\"Higher IER3 expression correlates with reduced response to immune checkpoint blockade and distinct drug sensitivity profiles.\"}]","IER3 Promotes Malignant Progression of Colorectal Cancer Through the NF-κB Pathway | PDF",1790098944,86,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6346a8b8a749c933db2d9874882add2.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b0854f5e7d50132af4fb381ba7d2c93.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3ebe8f24dfee1b20c23fa9502ca98c9.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/faf23281da7cfa83c4557d50838c704a.webp",980,1306]